SU5214

SU5214 is a potent VEGFR2 inhibitor extracted from patent US5834504A, SU5214, has IC50s of 14.8 µM (FLK-1) and 36.7 µM (EGFR), respectively[1].

VEGFR

Reference compound

Protein Tyrosine Kinase/RTK

Cancer-Kinase/protease

Cancer

https://www.medchemexpress.com/su5214.html

98.0

DMSO : 100 mg/mL (ultrasonic)

O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CC=C3OC

251.28

[1]Tang et al. 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease. US5834504A.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

http://file.medchemexpress.com/batch_PDF/HY-21292/SU5214-DataSheet-MedChemExpress.pdf

http://file.medchemexpress.com/batch_PDF/HY-21292/SU5214-SDS-MedChemExpress.pdf

No Development Reported

186611-04-1